SCHEMBL7669245

SCHEMBL7669245

CCCCCCCc1ccc(C(=O)Nc2ccc(S(=O)(=O)NCC(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
NPC1 O15118 2/20 0.48
GALR3 O60755 1/20 0.48
RAB9A P51151 1/20 0.48
TRPV1 Q8NER1 5/20 0.48
LMNA P02545 2/20 0.47
ALDH1A1 P00352 1/20 0.47
ENPP1 P22413 1/20 0.46
GHSR Q92847 1/20 0.46
PLK1 P53350 1/20 0.46
PRMT1 Q99873 2/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671606 1.00 KDM4E (0.52) KDM4ECA12CA1CA2CA9
SCHEMBL7673461 1.00 KDM4E (0.52) KDM4ECA12CA1CA2CA9
SCHEMBL7669959 0.99 KDM4E (0.53) KDM4ECA12CA1CA2CA9
SCHEMBL7674292 0.92 ENPP1 (0.54) KDM4ENPC1GALR3RAB9ALMNA
SCHEMBL7670801 0.88 LMNA (0.52) KDM4ENPC1RAB9ALMNAALDH1A1
SCHEMBL7667904 0.86 KDM4E (0.58) KDM4ECA12CA1CA2CA9
SCHEMBL7669110 0.86 KDM4E (0.58) KDM4ECA12CA1CA2CA9
SCHEMBL7667917 0.86 KDM4E (0.58) KDM4ECA12CA1CA2CA9
SCHEMBL7669588 0.84 KDM4E (0.59) KDM4ECA12CA1CA2CA9
SCHEMBL7667880 0.83 LMNA (0.54) KDM4ECA1CA2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed